Lataa...
Alteration of metabolite profiling by cold atmospheric plasma treatment in human myeloma cells
BACKGROUND: Despite new progress of chemotherapy in multiple myeloma (MM) clinical treatment, MM is still a refractory disease and new technology is needed to improve the outcomes and prolong the survival. Cold atmospheric plasma is a rapidly developed technology in recent years, which has been wide...
Tallennettuna:
| Julkaisussa: | Cancer Cell Int |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5859683/ https://ncbi.nlm.nih.gov/pubmed/29568236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-018-0541-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|